Figure 7From: Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationSignaling pathway activation of ER-positive MCF7 and T47D cell lines expressing wild-type (WT) or I767M mutant HER2. Whole-cell lysates of MCF7 and T47D, stably expressing empty vector control, wild-type HER2 or I767M mutant HER2 were analyzed by western blotting for total and phosphorylated levels of HER2, AKT, ERK1/2 and rpS6 on the same membrane, detected by near infrared two-color detection and quantified (LI-COR; Odyssey). Phospho-/total protein ratios are shown below. NRG1, neuregulin-1.Back to article page